162 related articles for article (PubMed ID: 8882036)
1. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology.
Hirschl M; Kundi M
J Rheumatol; 1996 Feb; 23(2):302-9. PubMed ID: 8882036
[TBL] [Abstract][Full Text] [Related]
2. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
3. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
[TBL] [Abstract][Full Text] [Related]
5. Raynaud's phenomenon: clinical spectrum of 118 patients.
De Angelis R; Del Medico P; Blasetti P; Cervini C
Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
[TBL] [Abstract][Full Text] [Related]
6. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
[TBL] [Abstract][Full Text] [Related]
7. Incidence of thoracic outlet syndrome on the epidemiology and clinical presentation of apparently primary Raynaud's phenomenon. A prospective study in 570 patients.
Pistorius MA; Planchon B
Int Angiol; 1995 Mar; 14(1):60-4. PubMed ID: 7658106
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Raynaud's phenomenon in a healthy Spanish population.
Riera G; Vilardell M; Vaqué J; Fonollosa V; Bermejo B
J Rheumatol; 1993 Jan; 20(1):66-9. PubMed ID: 8441168
[TBL] [Abstract][Full Text] [Related]
9. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
[TBL] [Abstract][Full Text] [Related]
10. The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon.
Anderson ME; Moore TL; Lunt M; Herrick AL
Rheumatology (Oxford); 2007 Mar; 46(3):533-8. PubMed ID: 17018538
[TBL] [Abstract][Full Text] [Related]
11. The incidence and natural history of Raynaud's phenomenon in the community.
Suter LG; Murabito JM; Felson DT; Fraenkel L
Arthritis Rheum; 2005 Apr; 52(4):1259-63. PubMed ID: 15818710
[TBL] [Abstract][Full Text] [Related]
12. Infrared-monitored cold response in the assessment of Raynaud's phenomenon.
Foerster J; Wittstock S; Fleischanderl S; Storch A; Riemekasten G; Hochmuth O; Meffert B; Meffert H; Worm M
Clin Exp Dermatol; 2006 Jan; 31(1):6-12. PubMed ID: 16309469
[TBL] [Abstract][Full Text] [Related]
13. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
14. Use of thermographic criteria to identify Raynaud's phenomenon in a population setting.
Cherkas LF; Carter L; Spector TD; Howell KJ; Black CM; MacGregor AJ
J Rheumatol; 2003 Apr; 30(4):720-2. PubMed ID: 12672189
[TBL] [Abstract][Full Text] [Related]
15. Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients.
Arpaia G; Cimminiello C; Bellone M; Aloisio M; Rossi F; Bonfardeci G
Int Angiol; 1994 Mar; 13(1):15-8. PubMed ID: 8077792
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
17. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
18. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
[TBL] [Abstract][Full Text] [Related]
19. Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population.
O'Keeffe ST; Tsapatsaris NP; Beetham WP
J Rheumatol; 1992 Sep; 19(9):1415-7. PubMed ID: 1433009
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Raynaud's phenomenon in 2 ethnic groups in the general population of Estonia.
Valter I; Maricq HR
J Rheumatol; 1998 Apr; 25(4):697-702. PubMed ID: 9558171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
